Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer

Immune checkpoint blockade has significantly improved clinical outcomes for patients with non-small cell lung cancer (NSCLC) and other solid tumours, but many patients do not respond and acquired resistance is common. Aspects of the tumour microenvironment linked to clinical outcomes include the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Jane, Salm, Max, Dangl, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216247/
https://www.ncbi.nlm.nih.gov/pubmed/35757302
http://dx.doi.org/10.1016/j.iotech.2019.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216247/
https://www.ncbi.nlm.nih.gov/pubmed/35757302
http://dx.doi.org/10.1016/j.iotech.2019.09.003

Ejemplares similares